AI Drug Companies Are Facing Challenges—but Don’t Blame the Technology
AI drug companies are struggling—but don’t blame the AI Moonshot hopes of artificial intelligence being used to expedite the development of drugs are coming back down to earth. More than $18 billion has flooded into more than 200 biotechnology companies touting AI to expedite development, with 75 drugs or vaccines entering clinical trials, according to […]